Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Accumulated Expenses: 2019-2022

Historic Accumulated Expenses for IM Cannabis (IMCC) over the last 4 years, with Dec 2022 value amounting to $1.4 million.

  • IM Cannabis' Accumulated Expenses fell 72.08% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $1.4 million, marking a year-over-year decrease of 72.08%. This contributed to the annual value of $1.4 million for FY2022, which is 71.02% down from last year.
  • Per IM Cannabis' latest filing, its Accumulated Expenses stood at $1.4 million for FY2022, which was down 71.02% from $4.9 million recorded in FY2021.
  • IM Cannabis' Accumulated Expenses' 5-year high stood at $886.6 billion during FY2020, with a 5-year trough of $1.4 million in FY2022.
  • For the 3-year period, IM Cannabis' Accumulated Expenses averaged around $295.5 billion, with its median value being $4.9 million (2021).
  • In the last 5 years, IM Cannabis' Accumulated Expenses skyrocketed by 118.42% in 2020 and then plummeted by 100.00% in 2021.
  • Over the past 4 years, IM Cannabis' Accumulated Expenses (Yearly) stood at $405.9 billion in 2019, then skyrocketed by 118.42% to $886.6 billion in 2020, then crashed by 100.00% to $4.9 million in 2021, then tumbled by 71.02% to $1.4 million in 2022.